Much of the April negotiations on the treaty for copyright exceptions for persons with disabilities was spent discussing the issue of countries that are not members of the WTO, or the Berne Convention, or countries classified by the UN as least developed countries (LDCs), and currently not bound by the TRIPS agreement provisions on copyright.
WIPO’s development agenda committee unfolds against the backdrop of a looming Millenium Development Goal deadline
3 June 2013
Kirsten Alisha Williams
WIPO’s development agenda committee unfolds against the backdrop of a looming Millenium Development Goal deadline
The agenda for the meeting is here: http://tacd-ip.org/archives/945
My slides are here.
Continue Reading
The drafting group has finished its work, and below is the “Final” text on the “Decisions Point” that will accompany the resolution on the CEWG work, it is very similar to the text from Friday, but stronger in some areas and perhaps not as good in some others. For example, on the topic of the finance mechanism, reference to “voluntary” has been eliminated.
Friday text: “demonstrate voluntary and sustainable financing mechanism.”
Saturday text: “propose and foster financing mechanisms including innovative, sustainable and pooled funding.”
On Friday, 24 May 2013, in the United States’ intervention to the 66th World Health Assembly’s deliberations on the Consultative Expert Working Group on R&D Financing, the US dropped a bombshell by proposing a decision point with the following language. We expect the Assembly to reconvene at 14:30 Geneva time and discuss the US proposal.
On May 17, 2013, DG trade held a public briefing on the IP Chapter for the TTIP and the E/Japan trade agreement. The TTIP discussion was led by Pedro Velasco Martins, the Deputy Head of Unit for Intellectual Property and Public Procurement. Unlike some recent USTR briefings, which were off-the-record, this was on-the-record meeting, and DG Trade even displayed a suggested twitter hash tag.
Below is a PDF from my presentation at the May 16, 2013 event in the EU Parliament on the Economic Crisis and Access to Medicines in Europe. While the main purpose of my talk was to discuss delinkage, I began with some data on the EU market and R&D outlays. I have pulled out one figure and two tables from the presentation and offer some comments here.
The figure below simulates the shape of the demand curve for Europe, if one assumes a constant elasticity of income for products, and insurance in each market.
|
| Markus Beyrer thinks blind people should not have robust copyright exceptions, because it might set a precedent for patents on health or climate technologies |
Joint Letter to the 66th World Health Assembly: Follow-up of the report of the CEWG
20 May 2013
Distinguished Delegate,
We urge the World Health Organization (WHO) and its Member States to exercise leadership, ambition and innovative thinking in developing new paradigms to take forward the work of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) in reconciling the objectives of stimulating medical innovation and ensuring access for all.
On Monday, 13 May 2013, the Supreme Court of the United States unanimously held that patent exhaustion does not apply to second, third or nth generations of seeds. In an opinion authored by Justice Kagan, the court found that patent exhaustion does not apply to seeds because later generations constitute new copies of the invention. Continue Reading